P3 Health Partners Inc. (PIII) Form 8-K — May 14, 2026
P3 Health Partners Inc. (PIII) reported a significant financial turnaround in its first quarter of 2026, posting a net income of $3.0 million compared to a net loss of $44.2 million in the same period last year. This improvement was driven by a 4% increase in total revenue to $386 million and a substantial expansion in medical margin to $73.7 million, reflecting the success of contract restructuring and network concentration efforts. The company raised its full-year 2026 Adjusted EBITDA guidance, setting a new midpoint of $40 million (range $20 million to $60 million), up from previous estimates.
Key figures
- Eps
- 0.37
- Revenue
- 386390000
- Guidance
- Full-year 2026 Adjusted EBITDA midpoint raised to $40 million (range $20M-$60M); Total Revenue $1.5B-$1.65B
- Net Income
- 3040000
- Revenue Yoy
- 4%
- Total Assets
- 674157000
- Cash Position
- 25497000
- At Risk Members
- 106000
- Medical Margin
- 73657000
- Adjusted Ebitda
- 25759000
- Medical Margin Pmpm
- 231
- Adjusted Ebitda Pmpm
- 81
- At Risk Members Yoy Change
- -10%
- Total Lives Under Management
- 135000
Price after filing
Close on the filing date to close N calendar days later (from $4.03). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.